Novel Remyelination Assay Allows High-Throughput Drug Screening
A new technology uses the actual myelin-making behavior of cells to look for drugs that may promote remyelination and prevent disability-causing nerve damage in people with MS. The first candidate is in clinical trials.
A new technology uses the actual myelin-making behavior of cells to look for drugs that may promote remyelination and prevent disability-causing nerve damage in people with MS. The first candidate is in clinical trials.
In the brains and spinal cords of people with multiple sclerosis, the repair of demyelinating lesions remains...
Clinical Research, Drug Development, Laboratory Research